Effects of statins on triglyceride metabolism (Q41731947)

8 October 2017

1 reference

title

Effects of statins on triglyceride metabolism (English)

1 reference

8 October 2017

1 reference

H N Ginsberg

1

1 reference

PubMed ID

9526811

8 October 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

American Journal of Cardiology

8 October 2017

1 reference

8 October 2017

81

1 reference

8 October 2017

32B-35B

1 reference

8 October 2017

4A

1 reference

Comparison of statins in hypertriglyceridemia

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Regulation of fatty acid synthase expression by cholesterol in human cultured cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Studies on rat liver phosphatidate phosphohydrolase and plasma lipids: effect of HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Cholesterol is required for secretion of very-low-density lipoprotein by rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Effect of lovastatin on the secretion of very low density lipoprotein lipids and apolipoprotein B in the hypertriglyceridemic Zucker obese rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Effect of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on triglyceride kinetics in chronically streptozotocin-diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Regulation of low density lipoprotein apoprotein B metabolism by lovastatin and cholestyramine in miniature pigs: effects on LDL composition and synthesis of LDL subfractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900035-6

10.1016/S0002-9149(98)00035-6

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9526811